Literature DB >> 29291

Correlation of the biological activity and solution conformation of [Asp1,Ile5]- and [Phe4,Tyr8]angiotensin II.

H E Bleich, R J Freer, S S Stafford, R E Galardy.   

Abstract

Angiotensin II is known to undergo a reversible conformational transition and a change in potency in rat uterus in vitro with pK approximately 6.5. We have shown by carbon-13 NMR that the conformational transition involves all-trans to partly cis isomerization of the His6-Pro7 peptide bond. Isomerization from all-trans at pH 6.8 to approximately 16% cis at pH 8.0 is therefore correlated with a 10-fold increase in biological activity for [Asp1,Ile5]-angiotensin II in rat uterus in vitro. Isomerization from all-trans at pH 6.8 to approximately 16% cis at pH 8.0 in the competitive inhibitor [Phe4,Tyr8]angiotensin II is correlated with exhibition of virtually no agonist activity at low pH to full agonist activity at high pH. An angiotensin II conformation with Pro7 in the cis form may therefore be the conformation with maximal binding or biological activity at the cellular receptor.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29291      PMCID: PMC392839          DOI: 10.1073/pnas.75.8.3630

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Conformational heterogeneity in linear peptides in solution: a carbon-1 3 NMR study of (Pro3, Pro5)-angiotensin-II.

Authors:  R Deslauriers; R A Komoroski; G C Levy; A C Paiva; I C Smith
Journal:  FEBS Lett       Date:  1976-02-01       Impact factor: 4.124

2.  A proposed conformation of isoleucyl-5-angiotensin II.

Authors:  R R SMEBY; K ARAKAWA; F M BUMPUS; M M MARSH
Journal:  Biochim Biophys Acta       Date:  1962-04-23

3.  Analogues of angiotensin II with restricted conformational freedom, including a new antagonist.

Authors:  J Turk; P Needleman; G R Marshall
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

4.  Conformational flexibility of angiotensin II. A carbon-13 spin-lattice relaxation study.

Authors:  R Deslauriers; A C Paiva; K Schaumburg; I C Smith
Journal:  Biochemistry       Date:  1975-03-11       Impact factor: 3.162

5.  pH titration effects on the CD spectra of angiotensin II, truncated peptides and other analogues: aromatic region.

Authors:  K Lintner; S Fermandjian; P Fromageot
Journal:  FEBS Lett       Date:  1975-08-15       Impact factor: 4.124

6.  Angiotensin-receptor interaction: influence of pH on angiotensin inhibition by Phe 4 -Tyr 8 -angiotensin II in rat uterine smooth muscle.

Authors:  P Needleman; R J Freer; G R Marshall
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-11

7.  Proposed models for angiotensin II in aqueous solution and conclusions about receptor topography.

Authors:  M P Printz; G Némethy; H Bleich
Journal:  Nat New Biol       Date:  1972-05-31

8.  Studies of angiotensin-II conformations by circular dichroism.

Authors:  S Fermandjian; J L Morgat; P Fromageot
Journal:  Eur J Biochem       Date:  1971-12

Review 9.  [Current problems of active substance research. 3. Structure-activity relationships of angiotensin II and analog].

Authors:  L Piesche; H Hilse; E Scheer
Journal:  Pharmazie       Date:  1974-04       Impact factor: 1.267

10.  Angiotensin II analogs. IX. Conformational studies of angiotensin II by proton magnetic resonance.

Authors:  R J Weinkam; E C Jorgensen
Journal:  J Am Chem Soc       Date:  1971-12-15       Impact factor: 15.419

View more
  1 in total

1.  Proton NMR studies of angiotensin II and its analogs in aqueous solution.

Authors:  N Zhou; G J Moore; H J Vogel
Journal:  J Protein Chem       Date:  1991-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.